In this inspiring video, Sam Tan, shares his story on battling lymphoma. Sam is the first in Singapore to have his Tcells (a type of white blood cell) genetically modified.

At Novartis, we are dedicated to developing innovative therapies for cancer and other lifethreatening diseases. We are pioneering the future and paving the way for innovation in cell and gene therapy.